David Smil

3.0k total citations
38 papers, 1.3k citations indexed

About

David Smil is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, David Smil has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in David Smil's work include Cancer-related gene regulation (11 papers), Epigenetics and DNA Methylation (10 papers) and Organoboron and organosilicon chemistry (6 papers). David Smil is often cited by papers focused on Cancer-related gene regulation (11 papers), Epigenetics and DNA Methylation (10 papers) and Organoboron and organosilicon chemistry (6 papers). David Smil collaborates with scholars based in Canada, United States and United Kingdom. David Smil's co-authors include Robert A. Batey, Avinash N. Thadani, Masoud Vedadi, Matthieu Schapira, Peter J. Brown, C.H. Arrowsmith, Alan J. Lough, Fengling Li, Mohammad S. Eram and Magdalena M. Szewczyk and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Biochemistry.

In The Last Decade

David Smil

38 papers receiving 1.3k citations

Peers

David Smil

ONCOL

Charles L. Cywin United States

Hachemi Kadri United Kingdom

Joseph S. Warmus United States

Carl Crysler United States

Srinivas Rao Kasibhatla United States

Achim Schlapbach Switzerland

Tony Raynham United Kingdom

Douglas G. Batt United States

Stanley D. Chamberlain United States

Peter W. Glunz United States

Charles L. Cywin United States

David Smil

506 ×0.6

573 ×1.0

160 ×1.1

ONCOL

72 ×0.7

45 ×0.8

Citations per year, relative to David Smil David Smil (= 1×) peers Charles L. Cywin

Countries citing papers authored by David Smil

Since Specialization

Citations

This map shows the geographic impact of David Smil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Smil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Smil more than expected).

Fields of papers citing papers by David Smil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Smil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Smil. The network helps show where David Smil may publish in the future.

Co-authorship network of co-authors of David Smil

This figure shows the co-authorship network connecting the top 25 collaborators of David Smil. A scholar is included among the top collaborators of David Smil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Smil. David Smil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Jong Fu, Carlos Zepeda‐Velázquez, Laurent Hoffer, et al.. (2024). Discovery of Conformationally Constrained ALK2 Inhibitors. Journal of Medicinal Chemistry. 67(6). 4707–4725. 3 indexed citations

Chen, Yun, et al.. (2022). A non-traditional crystal-based compound screening method targeting the ATP binding site of Plasmodium falciparum GRP78 for identification of novel nucleoside analogues. Frontiers in Molecular Biosciences. 9. 956095–956095. 3 indexed citations

Li, Alice, Dimitrios Panagopoulos, Fengling Li, et al.. (2021). Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics**. ChemMedChem. 16(7). 1116–1125. 11 indexed citations

Devkota, Kanchan, Matthieu Schapira, Sumera Perveen, et al.. (2021). Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors. SLAS DISCOVERY. 26(9). 1200–1211. 55 indexed citations

Smil, David, Carlos Zepeda‐Velázquez, Dimitrios Panagopoulos, et al.. (2020). Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma. Journal of Medicinal Chemistry. 63(9). 4978–4996. 15 indexed citations

Getlik, Matthäus, David Smil, Carlos Zepeda‐Velázquez, et al.. (2016). Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1). Journal of Medicinal Chemistry. 59(6). 2478–2496. 67 indexed citations

Hughes, Scott J., et al.. (2014). Structural characterization of a new N‐substituted pantothenamide bound to pantothenate kinases from Klebsiella pneumoniae and Staphylococcus aureus. Proteins Structure Function and Bioinformatics. 82(7). 1542–1548. 11 indexed citations

Bullwinkle, Tammy J., Shengwei Zou, Andrei Rajkovic, et al.. (2013). (R)-β-Lysine-modified Elongation Factor P Functions in Translation Elongation. Journal of Biological Chemistry. 288(6). 4416–4423. 45 indexed citations

Yu, Wenyu, David Smil, Fengling Li, et al.. (2013). Bromo-deaza-SAH: A potent and selective DOT1L inhibitor. Bioorganic & Medicinal Chemistry. 21(7). 1787–1794. 51 indexed citations

10.

Tempel, W., et al.. (2013). Crystal structures of Klebsiella pneumoniae pantothenate kinase in complex with N‐substituted pantothenamides. Proteins Structure Function and Bioinformatics. 81(8). 1466–1472. 12 indexed citations

11.

Bolshan, Yuri, Matthäus Getlik, Ekaterina Kuznetsova, et al.. (2013). Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction. ACS Medicinal Chemistry Letters. 4(3). 353–357. 46 indexed citations

12.

Tessier, Pierre, David Smil, Amal Wahhab, et al.. (2009). Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(19). 5684–5688. 45 indexed citations

13.

Smil, David, Sukhdev Manku, Silvana Leit, et al.. (2008). Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(3). 688–692. 73 indexed citations

14.

Wahhab, Amal, David Smil, Alain Ajamian, et al.. (2008). Sulfamides as novel histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(2). 336–340. 26 indexed citations

15.

Smil, David, Fabio E. S. Souza, & Alex G. Fallis. (2005). A general carbometalation, three component coupling strategy for the synthesis of α,β-unsaturated γ-sultines including thio-rofecoxib, a selective COX-2 inhibitor. Bioorganic & Medicinal Chemistry Letters. 15(8). 2057–2060. 14 indexed citations

16.

Thadani, Avinash N., Robert A. Batey, Alan J. Lough, & David Smil. (2002). (E)-2-Styryl-[1,3,6,2]dioxazaborolane. Acta Crystallographica Section E Structure Reports Online. 58(3). o238–o239. 2 indexed citations

17.

Batey, Robert A. & David Smil. (1999). Tethered α-boryl radical cyclizations of haloalkyl boronates. Tetrahedron Letters. 40(52). 9183–9187. 22 indexed citations

18.

Batey, Robert A. & David Smil. (1999). Erste durch Verknüpfung über Bor vermittelte radikalische Cyclisierungen und intramolekulare homolytische Substitutionen an Bor. Angewandte Chemie. 111(12). 1914–1917. 16 indexed citations

19.

Batey, Robert A. & David Smil. (1999). The First Boron-Tethered Radical Cyclizations and Intramolecular Homolytic Substitutions at Boron. Angewandte Chemie International Edition. 38(12). 1798–1800. 72 indexed citations

20.

Batey, Robert A., Avinash N. Thadani, & David Smil. (1999). Potassium allyl- and crotyltrifluoroborates: Stable and efficient agents for allylation and crotylation. Tetrahedron Letters. 40(23). 4289–4292. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact